Stemline Therapeutics Inc (NASDAQ:STML)

14.87
Delayed Data
As of 10:09am ET
 -0.38 / -2.49%
Today’s Change
10.50
Today|||52-Week Range
21.28
-12.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.00--76.7K--
 
 
 
Operating ExpensesGross Income0.000.00-76.7K0.00
 
 
General Expenses2.7M6.5M24.0M29.3M
 
 
 
 
 
Research And Development1.6M3.4M16.2M21.2M
 
 
 
 
 
Total Operating Expenses2.7M6.5M24.1M29.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-6.5M-24.1M-29.3M
 
 
 
 
 
Extraordinary Credit0.000.0030.4K--
 
 
Extraordinary Charge-9.7K0.000.00--
 
 
Interest Expense On Debt98.6K118.8K516.9K0.00
 
 
 
 
Other Expenses46.7K301.6K321.3K338.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-6.3M-24.2M-28.8M
 
 
 
 
 
Net Income-2.8M-6.3M-24.2M-28.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.0M7.5M10.3M12.9M
 
 
 
 
 
Shares To Calculate EPS Diluted7.0M7.5M10.3M12.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.80-$1.82-$2.35-$2.23
 
 
 
 
 
EPS Diluted-$0.40-$0.84-$2.35-$2.23
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account